Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

GYKI 52466 dihydrochloride, Tocris Bioscience™

Catalog No. 145450
Click to view available options
Quantity:
10 mg
50 mg
This item is not returnable. View return policy
This item is not returnable. View return policy

Selective non-competitive AMPA antagonist

GYKI 52466 dihydrochloride is a selective noncompetitive AMPA receptor antagonist (IC50 values are 10-20, ∼ 450 and >50 μM for AMPA-, kainate- and NMDA-induced responses respectively). Skeletal muscle relaxant and orally-active anticonvulsant. Has anti-proliferative effects in transformed cells.

Chemical Identifiers

CAS 2319722-40-0
Molecular Formula C17H15N3O2
Molecular Weight (g/mol) 293.326
InChI Key LFBZZHVSGAHQPP-UHFFFAOYSA-N
Synonym unii-471v8nz5x3, 1-p-aminophenyl-4-methyl-7,8-methylenedioxy-5h-2,3-benzodiazepine hydrochloride, 4-8-methyl-9h-1,3 dioxolo 4,5-h 2,3 benzodiazepin-5-yl aniline, 4-8-methyl-9h-1,3-dioxolo 4,5-h 2,3 benzodiazepin-5-yl benzenamine, benzenamine, 4-8-methyl-9h-1,3-dioxolo 4,5-h 2,3 benzodiazepin-5-yl, benzenamine,4-8-methyl-9h-1,3-dioxolo 4,5-h 2,3 benzodiazepin-5-yl, 1-4-aminophenyl-4-methyl-7,8-methylenedioxy-5h-2,3-benzodiazepine, gyki 52466 dihydrochloride, 4-8-methyl-9h-1,3 dioxolo 4',5':4,5 benzo 1,2-d 1,2 diazepin-5-yl aniline
PubChem CID 3538
ChEBI CHEBI:79560
IUPAC Name 4-(8-methyl-9H-[1,3]dioxolo[4,5-h][2,3]benzodiazepin-5-yl)aniline
SMILES CC1=NN=C(C2=CC3=C(C=C2C1)OCO3)C4=CC=C(C=C4)N

Specifications

Quantity 50 mg
Formula Weight 366.24
Percent Purity >99%
Chemical Name or Material GYKI 52466 dihydrochloride
Recommended Storage Desiccate at Room Temperature
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.